Why is Parmax Pharma falling/rising?

As of 21-Aug, Parmax Pharma Ltd is experiencing a decline in its stock price, currently at Rs 36.20, which reflects a decrease of Rs 2.0 or 5.24%. The stock has underperformed its sector by 5.7% today and has opened with a loss of 2.17%. It has also touched an intraday low of Rs 36.20. Over the past week, the stock has seen a decline of 6.07%, and its year-to-date performance shows a significant drop of 18.19%. The company is trading below all its moving averages, indicating a bearish trend. Additionally, the company has a negative book value and weak long-term fundamental strength, with net sales declining by 43.96% in the latest six months, contributing to the stock's downward movement.
In the broader market context, the Sensex has shown a positive return of 1.74% over the past week, contrasting sharply with Parmax Pharma's performance. This divergence highlights the stock's struggle relative to the market. The company's weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of 0.66, further exacerbates investor concerns. While there has been a notable increase in investor participation with a 325.46% rise in delivery volume, the overall sentiment remains negative due to the company's financial instability and poor growth prospects, leading to a strong sell recommendation.